CLINICAL EFFICACY OF A NEW, ENHANCED-POTENCY, INACTIVATED POLIOVIRUS VACCINE
- 31 March 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 331 (8591) , 897-899
- https://doi.org/10.1016/s0140-6736(88)91711-4
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- SEROLOGICAL COMPARISONS OF APPROACHES TO POLIO VACCINATION IN THE GAMBIAThe Lancet, 1987
- Serological evaluation of poliomyelitis oral and inactivated vaccines in an urban low-income population at Rio de Janeiro, BrazilVaccine, 1986
- INDUCTION OF LONG-TERM IMMUNITY TO PARALYTIC POLIOMYELITIS BY USE OF NON-INFECTIOUS VACCINEThe Lancet, 1984
- Industrial-Scale Production of Inactivated Poliovirus Vaccine Prepared by Culture of Vero Cells on MicrocarrierClinical Infectious Diseases, 1984
- Inactivated Poliovirus Vaccine: Current Production Methods and New DevelopmentsClinical Infectious Diseases, 1984
- Use of Killed Poliovirus Vaccine in a Routine Immunization Program in West AfricaClinical Infectious Diseases, 1984
- Clinical efficacy of rubella vaccineThe Pediatric Infectious Disease Journal, 1983
- The immunological response of Nigerian infants to attenuated and inactivated poliovaccinesPathogens and Global Health, 1978